Evidence map›Paper›PMID 38099302›Full record

ArticlePeerJ2023

A deep learning method for drug-target affinity prediction based on sequence interaction information mining.

Mingjian Jiang, Yunchang Shao, Yuanyuan Zhang, Wei Zhou, Shunpeng Pang

Abstract read
In one paragraph

Article in PeerJ, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mingjian Jiang *School of Information and Control Engineering, Qingdao University of Technology, Qingdao, Shandong, China.
Yunchang ShaoSchool of Information and Control Engineering, Qingdao University of Technology, Qingdao, Shandong, China.
Yuanyuan ZhangSchool of Information and Control Engineering, Qingdao University of Technology, Qingdao, Shandong, China.
Wei ZhouSchool of Information and Control Engineering, Qingdao University of Technology, Qingdao, Shandong, China.
Shunpeng Pang *School of Computer Engineering, WeiFang University, Weifang, Shandong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: A critical aspect of Methods: We proposed a novel sequence-based approach, named KC-DTA, for predicting drug-target affinity (DTA). In this approach, we converted the target sequence into two distinct matrices, while representing the molecule compound as a graph. The proposed method utilized k-mers analysis and Cartesian product calculation to capture the interactions and evolutionary information among various residues, enabling the creation of the two matrices for target sequence. For molecule, it was represented by constructing a molecular graph where atoms serve as nodes and chemical bonds serve as edges. Subsequently, the obtained target matrices and molecule graph were utilized as inputs for convolutional neural networks (CNNs) and graph neural networks (GNNs) to extract hidden features, which were further used for the prediction of binding affinity. Results: In order to evaluate the effectiveness of the proposed method, we conducted several experiments and made a comprehensive comparison with the state-of-the-art approaches using multiple evaluation metrics. The results of our experiments demonstrated that the KC-DTA method achieves high performance in predicting drug-target affinity (DTA). The findings of this research underscore the significance of the KC-DTA method as a valuable tool in the field of

Indexed as

Deep LearningBiological EvolutionDrug Delivery SystemsDrug DiscoveryConvolutional neural networkDeep learningDrug-target affinity predictionGraph neural networkProtein sequence

Identifiers

PMID38099302
PMCPMC10720480

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.